Jan 25, 2013 by Brenton FlynnWhy Celgene Still Looks CheapMotley Fool bureau chief Brenton Flynn discusses his key takeaways from the most notable health care industry earnings reports.
Jan 25, 2013 by Brenton FlynnIt's All Relative for This Biotech UnderperformerMotley Fool bureau chief Brenton Flynn discusses his key takeaways from the most notable health care industry earnings reports.
Jan 25, 2013 by Brenton FlynnFoolish Recap: Intuitive Surgical EarningsMotley Fool bureau chief Brenton Flynn discusses his key takeaways from the most notable health care industry earnings reports.
Jan 23, 2013 by Brenton FlynnIntuitive Surgical: 1 Thing Citron Got RightIntuitive Surgical beat earnings expectations handily.
Jan 22, 2013 by Brenton FlynnAfter Hours Surge: Intuitive Surgical's Clean Bill of HealthIntuitive knocks the cover off of the ball in Q4.
Jan 22, 2013 by Brenton FlynnSteady As She Goes at Johnson & JohnsonAs expected for the health care blue chip.
Jan 22, 2013 by Brenton FlynnAbbott and AbbVie's Last HurrahFor the last time, investors will see combined results from Abbott Labs and AbbVie
Jan 22, 2013 by Brenton FlynnReading the Johnson & Johnson Earnings Tea LeavesJ&J's earnings call presented a number of derivative investing insights
Jan 21, 2013 by Brenton FlynnWhat to Watch With WellPoint EarningsThe company's expected slight drop in revenue is coming as no surprise.
Jan 18, 2013 by Brenton FlynnJohnson & Johnson Earnings: What to WatchJohnson & Johnson will be releasing earnings next Tuesday. Here's what investors should look for.
Jan 18, 2013 by Brenton FlynnIntuitive Surgical Earnings: What to WatchIntuitive Surgical will be releasing earnings next Tuesday. Here are the important things to keep an eye on.
Jan 18, 2013 by Brenton FlynnNovartis Earnings: Patent Cliff EditionThe right way to handle a patent cliff.
Jan 18, 2013 by Brenton FlynnCubist Earnings: What to WatchWhile earnings can sometimes move the needle, this big drug is what investors should really be watching.
Jan 17, 2013 by Brenton FlynnDon't Sweat This Pharma's DebtAbbVie may look like it has a lot of debt, but it's not as simple as that.
Jan 17, 2013 by Brenton Flynn2 Speculative Stocks Soaring in 2013Pacific BioSciences and Peregrine are soaring, but buyer beware...
Jan 16, 2013 by Brenton FlynnBig Pharma's Special SauceSpecialty drugs are pharma's wave of the future
Jan 15, 2013 by Brenton FlynnWhat to Watch With UnitedHealth Group EarningsEarnings are coming out on Thursday the 17th. Here's what you need to be looking for.
Jan 15, 2013 by Brenton FlynnBig Pharma's Animal InstinctAnimal health, big pharma's emerging markets play.
